共 50 条
- [36] The impact of Bruton's tyrosine kinase inhibitor treatment on COVID-19 outcomes in Chinese patients with chronic lymphocytic leukemia FRONTIERS IN ONCOLOGY, 2024, 14
- [38] Ibrutinib as a Bruton Kinase Inhibitor in the Management of Chronic Lymphocytic Leukemia: A New Agent With Great Promise CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2016, 16 (02): : 63 - 69